| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.4 |